Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated (VRTX) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · VRTX · as of Jun 8, 2026
Key Statistics
Explore Vertex Pharmaceuticals Incorporated Data
vrtx stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 56 · Buy rate: 83.9%
The VRTX analyst consensus is Buy, based on ratings from 56 Wall Street analysts over the past 3 months. The average 12-month price target is $553.93, representing +23.97% upside from the current price of $446.83.
Competitors & Peers
vrtx competitorsVRTX
ARGX
BMY
CVS
GSK
HCAStock Performance
Full HistoryAbout Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDE…
what is vertex pharmaceuticals incorporated · vrtx stock overview · vertex pharmaceuticals incorporated company profile · who is vertex pharmaceuticals incorporated ceo · vrtx NASDAQ · vertex pharmaceuticals incorporated headquarters · vertex pharmaceuticals incorporated business segments
About Stock Overview & Key Data
Vertex Pharmaceuticals Incorporated (VRTX) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Jul 24, 1991. As of the latest trading session, VRTX stock price is $446.83, with a market capitalization of $113.4B. The stock has returned +0.15% over the past 12 months and -1.44% year-to-date.
According to 56 Wall Street analysts, the consensus rating for Vertex Pharmaceuticals Incorporated stock is Buy, with an average 12-month price target of $553.93. In fiscal year 2025, Vertex Pharmaceuticals Incorporated reported revenue of $12.1B and net income of $4.0B. For detailed data — including Vertex Pharmaceuticals Incorporated revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Vertex Pharmaceuticals Incorporated (VRTX) stock price is $446.83. The stock is traded on NASDAQ under the ticker symbol VRTX. The 52-week range is $362.50 – $507.92.